within Pharmacolibrary.Drugs.D_Dermatologicals.D10A_AntiAcnePreparationsForTopicalUse.D10AF51_ClindamycinCombinations;

model ClindamycinCombinations
  extends Pharmacolibrary.Drugs.ATC.D.D10AF51;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D10AF51</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Clindamycin, in combination with other agents (e.g., benzoyl peroxide), is a lincosamide antibiotic used primarily for the topical treatment of acne vulgaris. It acts by inhibiting bacterial protein synthesis. Clindamycin is well established and widely approved in such dermatological uses, particularly for mild to moderate acne.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters in healthy adults for topical clindamycin/benzoyl peroxide combination, as no compartmental PK models or direct systemic exposure data are reported in literature for this topical combination.</p><h4>References</h4><ol><li><p>Guay, DR (2007). Topical clindamycin in the management of acne vulgaris. <i>Expert opinion on pharmacotherapy</i> 8(15) 2625–2664. DOI:<a href=&quot;https://doi.org/10.1517/14656566.8.15.2625&quot;>10.1517/14656566.8.15.2625</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17931096/&quot;>https://pubmed.ncbi.nlm.nih.gov/17931096</a></p></li><li><p>Chassard, D, et al., &amp; Schmitz, V (2006). A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne. <i>The Journal of dermatological treatment</i> 17(3) 154–157. DOI:<a href=&quot;https://doi.org/10.1080/09546630600727115&quot;>10.1080/09546630600727115</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16854755/&quot;>https://pubmed.ncbi.nlm.nih.gov/16854755</a></p></li><li><p>van Hoogdalem, EJ (1998). Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. <i>Journal of the European Academy of Dermatology and Venereology : JEADV</i> 11 Suppl 1 S13–S29. DOI:<a href=&quot;https://doi.org/10.1111/j.1468-3083.1998.tb00902.x&quot;>10.1111/j.1468-3083.1998.tb00902.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9891904/&quot;>https://pubmed.ncbi.nlm.nih.gov/9891904</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end ClindamycinCombinations;
